AMH (Anti-Müllerian Hormone) is a biomarker of ovarian reserve, primarily used in fertility assessment. Some observational studies suggest that higher AMH levels (indicating later menopause) are associated with a modest increase in lifespan, possibly due to slower reproductive aging. However, the evidence is moderate: these are associations, not proven causality. Confounders such as lifestyle, genetics, and socioeconomic status are not always fully controlled. Additionally, AMH naturally declines with age, so a single measurement has limited predictive value for individual longevity. Currently, there is no established clinical link between AMH and longevity that would justify using AMH tests for life expectancy predictions. Caveat: AMH tests are validated for fertility, not for longevity. Do not base health decisions on such values without medical guidance.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-7b426b73c2d51f877c2a82fa